{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:14Z","timestamp":1786119554129,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/inf.0b013e3181f68e9c","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T14:48:09Z","timestamp":1284907689000},"page":"1111-1117","source":"Crossref","is-referenced-by-count":68,"title":["Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds"],"prefix":"10.1097","volume":"29","author":[{"given":"Kulkanya","family":"Chokephaibulkit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukiat","family":"Sirivichayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usa","family":"Thisyakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Sabchareon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitsanu","family":"Pancharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bouckenooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Gailhardou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Feroldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7883\/yoken.JJID.2009.331","article-title":"Japanese encephalitis in mainland china.","volume":"62","author":"Wang","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"R2-11-20210202","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1586\/erv.09.69","article-title":"Japanese encephalitis: is there a need for a novel vaccine?","volume":"8","author":"Wilder-Smith","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R3-11-20210202","first-page":"49","article-title":"Japanese encephalitis globally and in India.","volume":"48","author":"Jacobson","year":"2004","journal-title":"Indian J Public Health"},{"issue":"RR-1","key":"R5-11-20210202","first-page":"1","article-title":"Inactivated Japanese encephalitis virus vaccine. Recommendations of the advisory committee on immunization practices (ACIP).","volume":"42","year":"1993","journal-title":"Morb Mortal Wkly Rep Recomm Rep"},{"key":"R6-11-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.epirev.a036087","article-title":"The epidemiology of Japanese encephalitis: prospects for prevention.","volume":"14","author":"Vaughn","year":"1992","journal-title":"Epidemiol Rev"},{"key":"R7-11-20210202","first-page":"311","article-title":"Vaccines. 5th ed.","author":"Halstead","year":"2008"},{"key":"R8-11-20210202","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2004.11.040","article-title":"Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health; April 26\u201327, 2004; Bangkok, Thailand.","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"R9-11-20210202","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines.","volume":"319","author":"Hoke","year":"1998","journal-title":"N Engl J Med"},{"key":"R10-11-20210202","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4269\/ajtmh.1999.61.288","article-title":"Japanese encephalitis vaccine (inactivated, biken) in US soldiers: immunogenicity and safety of vaccine in two dosing regimens.","volume":"61","author":"DeFraites","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"R11-11-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/infdis\/171.4.1074","article-title":"Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.","volume":"171","author":"Gambel","year":"1995","journal-title":"J Infect Dis"},{"key":"R12-11-20210202","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0140-6736(91)91531-X","article-title":"Adverse reactions to Japanese encephalitis vaccine.","volume":"338","author":"Ruff","year":"1991","journal-title":"Lancet"},{"key":"R13-11-20210202","first-page":"689","article-title":"A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.","volume":"26","author":"Nimmannitya","year":"1995","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R14-11-20210202","first-page":"242","article-title":"Global Advisory Committee on Vaccine Safety, 9\u201310 June 2005[in English, French].","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"R15-11-20210202","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States.","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"key":"R16-11-20210202","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"key":"R17-11-20210202","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties.","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"key":"R18-11-20210202","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"R19-11-20210202","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for chimerivax: recombinant live, attenuated vaccines against flavivirus infections.","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"R20-11-20210202","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (Chimerivax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"key":"R21-11-20210202","first-page":"113","article-title":"A simple micro-culture method for the study of group B arboviruses.","volume":"40","author":"De Madrid","year":"1969","journal-title":"Bull World Health Organ"},{"key":"R22-11-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.99.2.285","article-title":"A plaque reduction test for dengue virus neutralizing antibodies.","volume":"99","author":"Russell","year":"1967","journal-title":"J Immunol"},{"key":"R23-11-20210202","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004.","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"R24-11-20210202","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.","volume":"74","author":"Monath","year":"2000","journal-title":"J Virol"},{"key":"R25-11-20210202","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"R26-11-20210202","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/517323","article-title":"Short-term safety of live attenuated Japanese encephalitis vaccine (SA14\u201314\u20132): results of a randomized trial with 26,239 subjects.","volume":"176","author":"Liu","year":"1997","journal-title":"J Infect Dis"},{"key":"R27-11-20210202","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2008.02.042","article-title":"Comparison of the immunogenicity and safety of measles vaccine administered alone or with live attenuated Japanese encephalitis SA-14\u201314\u20132 vaccine in Philippine infants.","volume":"26","author":"Gatchalian","year":"2008","journal-title":"Vaccine"},{"key":"R28-11-20210202","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4269\/ajtmh.2006.75.659","article-title":"Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever\/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE).","volume":"75","author":"Reid","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"R29-11-20210202","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2000.62.480","article-title":"Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF\/JE SA14\u201314\u20132), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes.","volume":"62","author":"Bhatt","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"R30-11-20210202","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","article-title":"Recombinant, chimaeric live, attenuated vaccine (ChimeriVax-JE) incorporating the envelope genes of Japanese encephalitis (SA14\u201314\u20132) virus and the capsid and non-structural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"R31-11-20210202","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera against ChimeriVax-JE experimental vaccine.","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"key":"R32-11-20210202","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1086\/648407","article-title":"Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants.","volume":"200","author":"Chau","year":"2009","journal-title":"J Infect Dis"},{"key":"R33-11-20210202","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero","year":"2009","journal-title":"Pediatrics"},{"key":"R34-11-20210202","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens.","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"key":"R35-11-20210202","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"R36-11-20210202","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00144420","article-title":"Persistence of immunity to poliomyelitis among a southern population that received four doses of OPV 5 to over 15 years before.","volume":"12","author":"Triassi","year":"1996","journal-title":"Eur J Epidemiol"},{"key":"R37-11-20210202","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine.","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"R38-11-20210202","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1586\/erv.09.112","article-title":"Ixiaro: a new vaccine against Japanese encephalitis.","volume":"8","author":"Jelinek","year":"2009","journal-title":"Expert Rev Vaccines"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e3181f68e9c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:34:10Z","timestamp":1786041250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201012000-00011"}},"subtitle":["Multicenter Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181f68e9c","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}